Through our Clinical Trial Outcome Databases we enable clients to capture summary level data for the clinical safety and efficacy outcomes from publicly available data sources. For this, we have collaborated with Quantitative Solutions Inc. (QS) to market the existing QS core Clinical Trial Outcome Databases and to develop/market additional databases in selected disease areas. QS, founded by Jaap Mandema and Russ Wada, is a leading scientific consultancy service provider to the Pharmaceutical and Biotech industry. It develops quantitative models of clinical PK, efficacy and safety data to enable better Drug Development decisions.
Currently available databases
Why use CTO Database?
|Know more||Know more||Know more|
We have designed these databases to assist clients in conducting comparative efficacy and safety analysis, linking/scaling biomarkers to clinical outcomes, predicting/improving trial outcome and developing product differentiation strategies. They are further supported by customization and M&S consulting services provided by GVK BIO and QS, respectively, to ensure maximum flexibility and benefits.